Some antibody-drug conjugates may cause such significant ocular toxicity that patients have vision damage or have to stop ...

The arrest in the slaying of UnitedHealthcare CEO Brian Thompson was the first step to putting his alleged killer behind bars ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

With an accuracy of 86%, the biomarker panel has the potential to be clinically useful in diagnosis, management, and ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today. The company’s shares opened today at ...

The incidence and prevalence of genital herpes simplex virus (HSV) type 1 and 2 infections are high worldwide, contributing ...

Advances in peptide drug development and the rising prevalence of hematological disorders are driving demand for peptide-based therapeu ...

The blow fill seal technology market is expected to grow from its estimated USD 3,107.8 million in 2024 to USD 5,258.5 million in 2034. Between 2024 and 2034, sales are expected to increase at a ...

Background With higher valency pneumococcal vaccines on the horizon and new adult immunisation strategies under discussion, ...

Tempus AI leverages AI for precision medicine, offering genomics, data services, and AI applications. Click here to read an ...

Discover top strategies for patient-centricity in pharma, fostering trust through personalized care, transparent communication, and patient engagement.